Biogen Pharmachem Industries Ltd
BIOGENBiogen Pharmachem Industries Ltd
BIOGEN
Price Chart
Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
HighShowing good signs of profitability & efficiency
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -241.85 | 1.45 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 23.30 | 3.52 | 1.25% |
Forecast & Ratings
Detailed Forecast Price
Price Upside
Earnings
Earnings Growth
Revenue
Rev. Growth
Company Profile
Sun Techno Overseas Ltd. invests and trades in shares and securities. It trades in commodities, including agro based and precious metals, and other goods in present and future markets.
Get more out of Tickertape, Go Pro!
Customise key metrics, see detailed forecasts, download stock data and more
Forecasts
Price
Revenue
Earnings
Price Forecast
Hmm, looks like data is unavailable here. Please come back after some timeRevenue Forecast
Hmm, looks like data is unavailable here. Please come back after some timeEarnings Per Share Forecast
Hmm, looks like data is unavailable here. Please come back after some timeIncome
Balance Sheet
Cash Flow
Income Statement
| Financial Year | FY 2016 | FY 2017 | FY 2018 | FY 2019 | FY 2020 | FY 2021 | FY 2022 | FY 2023 | FY 2024 | TTM | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0.00 | 0.00 | 0.16 | 0.95 | 0.00 | 1.62 | 2.48 | 0.91 | 2.38 | 0.13 | ||||||||||
Raw Materials | 0.02 | — | — | — | — | — | — | — | — | 0.47 | ||||||||||
| Power & Fuel Cost | — | — | — | — | — | — | — | — | ||||||||||||
| Employee Cost | 0.01 | 0.03 | 0.04 | 0.04 | 0.01 | 0.05 | 0.17 | 0.08 | ||||||||||||
| Selling & Administrative Expenses | — | — | — | — | — | — | — | — | ||||||||||||
| Operating & Other expenses | 0.12 | 6.69 | 0.92 | 0.08 | 3.21 | 2.43 | 0.28 | 0.37 | ||||||||||||
EBITDA | -0.02 | -0.13 | -6.56 | -0.01 | -0.12 | -1.60 | 0.00 | 0.46 | 1.93 | -0.34 | ||||||||||
| Depreciation/Amortization | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| PBIT | -0.02 | -0.13 | -6.56 | -0.01 | -0.12 | -1.60 | 0.00 | 0.46 | 1.93 | -0.34 | ||||||||||
| Interest & Other Items | — | — | — | — | — | — | — | — | — | — | ||||||||||
| PBT | -0.02 | -0.13 | -6.56 | -0.01 | -0.12 | -1.60 | 0.00 | 0.46 | 1.93 | -0.34 | ||||||||||
| Taxes & Other Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | ||||||||||
| Net Income | -0.02 | -0.13 | -6.56 | -0.01 | -0.12 | -1.60 | 0.00 | 0.46 | 1.93 | -0.34 | ||||||||||
| EPS | -0.00 | -0.00 | -0.10 | -0.00 | -0.00 | -0.02 | 0.00 | 0.01 | 0.03 | -0.01 | ||||||||||
| DPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | ||||||||||
| Payout ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Company Updates
Annual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFAnnual report
PDFPeers & Comparison
Hmm, looks like data is unavailable here. Please come back after some time.Shareholdings
Promoter Holdings Trend
Total Promoter Holding
In last 6 months, promoter holding in the company has almost stayed constant
Low Pledged Promoter Holding
Pledged promoter holdings is insignificant
Institutional Holdings Trend
Increased Total Retail Holding
In last 3 months, retail holding in the company has increased by 1.00%
Foreign Institutional Holding
In last 3 months, foreign institutional holding of the company has almost stayed constant
Shareholding Pattern
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Shareholding History
smallcases
Looks like this stock is not in any smallcase yet.
Events
Dividend Trend
No Dividends
BIOGEN has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
Hmm, looks like data is unavailable here. Please come back after some timeNet loss of Biogen Pharmachem Industries reported to Rs 1.00 crore in the quarter ended September 2024 as against net profit of Rs 0.72 crore during the previous quarter ended September 2023. There were no Sales reported in the quarter ended September 2024 and during the previous quarter ended September 2023.Powered by Capital Market - Live
Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 13 November 2024.Powered by Capital Market - Live
Biogen Pharmachem Industries announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Biogen Pharmachem Industries announced that the Annual General Meeting (AGM) of the company will be held on 28 September 2024.Powered by Capital Market - Live
Biogen Pharmachem Industries has revised the meeting of the Board of Directors which was scheduled to be held on 9 August 2024. The meeting will now be held on 13 August 2024.Powered by Capital Market - Live
Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 9 August 2024.Powered by Capital Market - Live
Net loss of Biogen Pharmachem Industries reported to Rs 0.16 crore in the quarter ended June 2024 as against net profit of Rs 0.41 crore during the previous quarter ended June 2023. There were no Sales reported in the quarter ended June 2024 and during the previous quarter ended June 2023.Powered by Capital Market - Live
Biogen Pharmachem Industries will hold a meeting of the Board of Directors of the Company on 1 August 2024.Powered by Capital Market - Live
BRIEF-Sun Techno Overseas Approves Appointment Of Akshay Makadiya As CFO - Investing.com India
Matching Industry Revenue Growth
Over the last 5 years, revenue has grown at a yearly rate of 20.16%, vs industry avg of 20.16%
Constant Market Share
Over the last 5 years, market share stayed at 100%